PSGL-1/CD162 Antibody (PSGL1/1567)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-07820
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgM Kappa Clone # PSGL1/1567
Concentration
0.2 mg/ml
Product Summary for PSGL-1/CD162 Antibody (PSGL1/1567)
Immunogen
Recombinant human PSGL-1/CD162 protein (Uniprot: Q14242)
Localization
Cell Surface
Clonality
Monoclonal
Host
Mouse
Isotype
IgM Kappa
Description
200ug/ml of antibody purified from Bioreactor Concentrate by Column Chromatography. Prepared in 10 mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0 mg/ml. (NBP3-08695)
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Applications for PSGL-1/CD162 Antibody (PSGL1/1567)
Application
Recommended Usage
Flow Cytometry
1-2 ug/million cells
Immunocytochemistry/ Immunofluorescence
1-2 ug/ml
Application Notes
Optimal dilution for a specific application should be determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Column Chromatography
Formulation
10 mM PBS with 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: PSGL-1/CD162
Long Name
P-Selectin Glycoprotein Ligand 1
Alternate Names
CD162, PSGL1, SELPLG
Gene Symbol
SELPLG
UniProt
Additional PSGL-1/CD162 Products
Product Documents for PSGL-1/CD162 Antibody (PSGL1/1567)
Product Specific Notices for PSGL-1/CD162 Antibody (PSGL1/1567)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...